Private company
Trubion
Trubion was a publicly held biopharmaceutical company that was focused on creating a pipeline of protein-based therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. Trubion was acquired by Emergent BioSolutions on October 28, 2010.2 It was founded in 1999.1 It is headquartered in Seattle.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industrypharmaceutical industry1
- HeadquartersSeattle1
- Websitewww.trubion.com
- Listed onNasdaq1
See how the biggest companies compare on our leaderboards
Trubion was a publicly held biopharmaceutical company that was focused on creating a pipeline of protein-based therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. Trubion was acquired by Emergent BioSolutions on October 28, 2010.2
Timeline
- 1999Founded Founded1
Links
- Websitewww.trubion.com1
- WikipediaTrubion
- WikidataQ7847126
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataTrubion on Wikidata
- 2WikipediaTrubion on Wikipedia